Top Markets
#1 Nesa Nesa +437.05%
#2 Prom Prom +32.69%
#3 MetaDAO MetaDAO +29.39%
#4 Bedrock Bedrock +12.45%
#5 Pons Pons +12.01%
#6 dogwifhat dogwifhat +11.31%
#7 Venom Venom +10.88%
#8 Cash Cat Cash Cat +9.94%
#9 Utya Utya +9.83%
#10 cat in a dogs world cat in a dogs world +9.57%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Celltrion, Inc. Celltrion, Inc.

Celltrion, Inc.

068270
Rank in Stocks #829
Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the... Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the development and manufacturing of protein-based therapies, including treatments for oncology. Its commercial portfolio features established products such as Remsima, Truxima, and Herzuma, alongside a range of generic pharmaceuticals and diagnostic kits for COVID-19. The company maintains an extensive pipeline of antibody biosimilars currently undergoing various stages of clinical evaluation. Late-stage (Phase 3) candidates include CT-P17, aimed at rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease (IBD); CT-P16, targeting metastatic colorectal and breast cancers; CT-P43, for inflammatory conditions like psoriasis, Crohn's disease, and ulcerative colitis; CT-P42, addressing diabetic macular edema; and CT-P59, developed for COVID-19. In Phase 2, CT-P27 is being tested for pandemic and seasonal influenza. Earlier in development, Phase 1 assets comprise CT-P39 for asthma and urticaria, CT-P41 for osteoporosis and bone loss, and CT-G20 for cardiomyopathy. Additionally, Celltrion maintains a collaboration with Inhalon Biopharma, Inc. to advance IN-006, an inhaled formulation of regdanvimab intended for the treatment of COVID-19 patients. Established in 2002, the company operates primarily from its headquarters in Incheon, South Korea.
Share Price
$132.28
Market Cap
$30.34B
Change (1 day)
-1.39%
Change (1 year)
10.77%
Country
KR
Trade Celltrion, Inc. (068270)

Category

Healthcare
Stock price history for Celltrion, Inc. (068270)
Highest end of day price: $137.00 on 2026-08-01

Lowest end of day price: $4.23 on 2005-07-01
Stock price history of Celltrion, Inc. from 2005 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 7.65%
2025 4.60%
2024 -3.56%
2023 3.81%
2022 -20.29%
2021 -45.68%
2020 128.22%
2019 -24.07%
2018 8.47%
2017 118.41%
2016 24.48%
2015 96.93%
2014 -5.33%
2013 46.20%
2012 -19.43%
2011 8.13%
2010 134.41%
2009 101.37%
2008 89.98%
2007 -33.41%
2006 -27.08%
2005 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.76 41.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.01K 49.43%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.48 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $139.50 450.30%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 7.57%
CH